scholarly journals In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

2012 ◽  
Vol 7 (1) ◽  
pp. 52 ◽  
Author(s):  
Markus Thiemann ◽  
Susanne Oertel ◽  
Volker Ehemann ◽  
Wilko Weichert ◽  
Albrecht Stenzinger ◽  
...  
Keyword(s):  
Mouse Model ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Hydroxamic Acid ◽  
Suberoylanilide Hydroxamic Acid ◽  
Malignant Rhabdoid Tumor ◽  
In Vivo Efficacy ◽  
Deacetylase Inhibitor ◽  
Tumor Mouse Model

In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer

2007 ◽  
Vol 104 (3) ◽  
pp. 596-601 ◽  
Author(s):  
Amy L. Cooper ◽  
Victoria L. Greenberg ◽  
Pamela S. Lancaster ◽  
John R. van Nagell ◽  
Stephen G. Zimmer ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Hydroxamic Acid ◽  
Inhibitor Therapy ◽  
Suberoylanilide Hydroxamic Acid ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document